Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorecta...

por Van Cutsem, Eric, Huijberts, Sanne, Grothey, Axel, Yaeger, Rona, Cuyle, Pieter-Jan, Elez, Elena, Fakih, Marwan, Montagut, Clara, Peeters, Marc, Yoshino, Takayuki, Wasan, Harpreet, Desai, Jayesh, Ciardiello, Fortunato, Gollerkeri, Ashwin, Christy-Bittel, Janna, Maharry, Kati, Sandor, Victor, Schellens, Jan H.M., Kopetz, Scott, Tabernero, Josep
Publicado 2019

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the...

por Tabernero, Josep, Grothey, Axel, Van Cutsem, Eric, Yaeger, Rona, Wasan, Harpreet, Yoshino, Takayuki, Desai, Jayesh, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod Kyrre, Arkenau, Hendrik-Tobias, Garcia-Alfonso, Pilar, Elez, Elena, Gollerkeri, Ashwin, Maharry, Kati, Christy-Bittel, Janna, Kopetz, Scott
Publicado 2021

Targeting Leukemia Stem Cells in vivo with AntagomiR-126 Nanoparticles in Acute Myeloid Leukemia

por Dorrance, Adrienne M., Neviani, Paolo, Ferenchak, Greg J., Huang, Xiaomeng, Nicolet, Deedra, Maharry, Kati S., Ozer, Hatice G, Hoellarbauer, Pia, Khalife, Jihane, Hill, Emily B., Yadav, Marshleen, Bolon, Brad N., Lee, Robert J., Lee, L.James, Croce, Carlo M., Garzon, Ramiro, Caligiuri, Michael A., Bloomfield, Clara D., Marcucci., Guido
Publicado 2015

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

por Whitman, Susan P., Kohlschmidt, Jessica, Maharry, Kati, Volinia, Stefano, Mrózek, Krzysztof, Nicolet, Deedra, Schwind, Sebastian, Becker, Heiko, Metzeler, Klaus H., Mendler, Jason H., Eisfeld, Ann-Kathrin, Carroll, Andrew J., Powell, Bayard L., Carter, Thomas H., Baer, Maria R., Kolitz, Jonathan E., Park, Il-Kyoo, Stone, Richard M., Caligiuri, Michael A., Marcucci, Guido, Bloomfield, Clara D.
Publicado 2013

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

por Niederwieser, Christian, Kohlschmidt, Jessica, Volinia, Stefano, Whitman, Susan P., Metzeler, Klaus H., Eisfeld, Ann-Kathrin, Maharry, Kati, Yan, Pearlly, Frankhouser, David, Becker, Heiko, Schwind, Sebastian, Carroll, Andrew J., Nicolet, Deedra, Mendler, Jason H., Curfman, John P., Wu, Yue-Zhong, Baer, Maria R., Powell, Bayard L., Kolitz, Jonathan E., Moore, Joseph O., Carter, Thomas H., Bundschuh, Ralf, Larson, Richard A., Stone, Richard M., Mrózek, Krzysztof, Marcucci, Guido, Bloomfield, Clara D.
Publicado 2014